T-Cypher Bio
T‑Cypher Bio is seeking a motivated protein engineer to drive the screening and characterization of soluble TCR proteins within its bispecific engineering pipeline. The role involves cloning, high‑throughput expression, purification, and biophysical analysis of recombinant TCRs, as well as contributing to project meetings and maintaining rigorous laboratory practices.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2021
At T-Cypher, we develop drugs against novel disease-specific targets to improve the lives of patients with cancer and autoimmune diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for T-Cypher Bio.
T-Cypher Bio didn’t post a salary, so this is our estimate from similar listings.